Off the wire
15 pct of Vietnamese population suffer from mental disorders  • Malaysian PM Najib calls for election preparations  • Swimming, cycling, aerobics offer "life-saving benefits": research  • Tokyo shares close higher by break on upbeat U.S. data  • Shallow quake strikes off eastern Indonesia  • New Zealand backs Aleppo ceasefire demand in UN Security Council  • S. Africa resolves to keep President Zuma in power  • Xinhua China news advisory -- Nov. 30  • S.Korea's industrial output falls on Galaxy Note 7 discontinuation, labor strike  • China treasury bond futures open lower Wednesday  
You are here:   Home

High-risk melanoma skin cancer patients should be monitored in specialized clinics: Aussie researchers

Xinhua, November 30, 2016 Adjust font size:

Australians who are at very high risk of melanoma skin cancer should be regularly monitored in specialized surveillance clinics for better treatment, according to latest research in the country.

Such clinics that can include regular monitoring by total body and close-up digital imaging would "cut costs and improve health outcomes as melanoma in this 'very high risk' group would be detected earlier and fewer unnecessary biopsies would be done," the Melanoma Institute Australia, a major melanoma research and treatment center which carried out the latest study, said in a media release Wednesday.

Melanoma is considered one of the deadliest skin cancers. Australia has one of the highest rates of melanoma in the world and the disease is often referred to as its "national cancer," the institute said. More than 13,000 Australians are expected to be diagnosed with melanoma in 2016.

Professor Graham Mann, the institute's research director, said the proposed surveillance would be a "win-win for patients and the national health budget."

"This is a disciplined, low tech but expert procedure that can and should be implemented by the Australian health care system," Mann said.

"It would save more lives and help reduce the costs of melanoma detection and treatment." Endit